- Home
- RCKT vs SPNS Comparison
RCKT vs SPNS Comparison
Compare RCKT & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- SPNS
- Stock Information
- Founded
- RCKT 1999
- SPNS 1982
- Country
- RCKT United States
- SPNS Israel
- Employees
- RCKT 299
- SPNS N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- RCKT Health Care
- SPNS Technology
- Exchange
- RCKT Nasdaq
- SPNS Nasdaq
- Market Cap
- RCKT 264.0M
- SPNS 1.6B
- IPO Year
- RCKT N/A
- SPNS 1992
- Fundamental
- Price
- RCKT $2.81
- SPNS $29.81
- Analyst Decision
- RCKT Buy
- SPNS Buy
- Analyst Count
- RCKT 13
- SPNS 4
- Target Price
- RCKT $18.50
- SPNS $34.25
- AVG Volume (30 Days)
- RCKT 4.2M
- SPNS 158.6K
- Earning Date
- RCKT 08-04-2025
- SPNS 07-31-2025
- Dividend Yield
- RCKT N/A
- SPNS 2.02%
- EPS Growth
- RCKT N/A
- SPNS 11.11
- EPS
- RCKT N/A
- SPNS 1.30
- Revenue
- RCKT N/A
- SPNS $544,235,000.00
- Revenue This Year
- RCKT N/A
- SPNS $8.30
- Revenue Next Year
- RCKT N/A
- SPNS $7.42
- P/E Ratio
- RCKT N/A
- SPNS $23.15
- Revenue Growth
- RCKT N/A
- SPNS 3.84
- 52 Week Low
- RCKT $2.19
- SPNS $23.69
- 52 Week High
- RCKT $26.98
- SPNS $41.22
- Technical
- Relative Strength Index (RSI)
- RCKT 40.19
- SPNS 60.32
- Support Level
- RCKT $2.40
- SPNS $28.44
- Resistance Level
- RCKT $2.96
- SPNS $29.56
- Average True Range (ATR)
- RCKT 0.21
- SPNS 0.53
- MACD
- RCKT 0.15
- SPNS 0.09
- Stochastic Oscillator
- RCKT 61.65
- SPNS 74.49
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.